Detailled Information

Name of the Instrument/Tool Digital Ulcer Clinical Assessment Score (DUCAS)
First Description

Bruni C, Ngcozana T, Braschi F, Pucci T, Piemonte G, Benelli L, et al. Preliminary Validation of the Digital Ulcer Clinical Assessment Score in Systemic Sclerosis. J Rheumatol. 2019;46(6):603-608.

Year 2019
Domains
Concept of constructs Damage
Population/Disease Disease specific
Originally developed for Systemic sclerosis
Other rheumatic diseases
where can be applied (only if validated)
---
Additional population with no rheumatic diseases No
Language: Originally published in English
Available in Language Italian
REFERENCE IDENTIFICATION
Author/s Bruni C, Ngcozana T, Braschi F, Pucci T, Piemonte G, Benelli L, Poli M, Suliman YA, Guiducci S, Bellando-Randone S, Balduzzi S, Grotts J, Denton CP, Rasero L, Montecucco C, Furst DE, Matucci-Cerinic M
Title Preliminary Validation of the Digital Ulcer Clinical Assessment Score in Systemic Sclerosis
Journal J Rheumatol
Year 2019
Vol 46
Num 6
Pages 603-608
Country Italy
Language English
Other references of interest
Link https://pubmed.ncbi.nlm.nih.gov/33091259/
Brief Description

An Update of Outcome Measures in Systemic Sclerosis

Link https://www.researchgate.net/publication/328972828_Prelimina …
Brief Description

Preliminary Validation of the DUCAS

Instrument/Tool Translations References
No other References.
DEVELOPER CONTACT INFORMATION
Correspondence to Cosimo Bruni
E-Mail cosimobruni85@gmail.com
Address ---
Website ---
Available ---
Links ---
DESCRIPTION OF THE INSTRUMENT
Type Of Measure Scale
Brief Description

The DUCAS is a clinical score for SSc-related DU. For this score, a DU is defined as “a loss of epidermal covering with a break in the basement membrane; appearing clinically as visible blood vessels, fibrin, granulation tissue and/or underlying deeper structures or as it would be appear on debridement”.

Number of Items 7
Range 0 to 19.5
Responses options/scale No
Developed for Clinical practice, Research
PRACTICAL APPLICATION
Method of administration Physician
Recommendations to score

The score is calculated from the sum of the seven items. The DUCAS includes items on the number of DUs, new DUs since the last evaluation, gangrene, need for surgical procedures beyond the usual standard of care, infection, need for hospitalization for DU-related issues, and need for analgesics to control DU-induced pain. Each item has its own set of variables and their associated scores. The categorical variables were assumed to be equally spaced.

Score Interpretation Higher scores indicate higher damage
Cut-off points The mean number of DU requiring treatment was 2.0 ± 1.4
Cut-off points applied to ---
Smallest detectable change if described ---
Smallest detectable change applied to ---
Completion time by the patient - minutes
Scoring time by the assessor - minutes
Training to score Not necessary
Strengths Useful in clinical practice & research, Easy to use
Limitations ---
OTHER COMMENTS
Other Comments

DUCAS has preliminary validity with face, content, and construct validity, and good correlation with disability/functionality indices. Completion of full validation in SSc, using Outcome Measures in Rheumatology (OMERACT) criteria, and including responsiveness and discrimination, remains to be done.